The Delta variant has hit Israel, but health officials have reason to be optimistic

Israel, where about 57 percent of the population is fully vaccinated, is seeing a resurgence in COVID-19 infections. "Dozens of new cases recently emerged at schools in two cities, Modiin and Binyamina, leading to hundreds of people being quarantined," The New York Times reports. "Israel has made 12- to 15-year-olds eligible for vaccination, but many have yet to get shots." Some Israeli health officials and experts blamed the uptick in cases on the more transmissible Delta variant that has swept through India and Britain, and the country reimposed an indoor mask mandate on Friday, two weeks after it was lifted.
"Despite the new outbreak, the country's current death rate remains close to zero," the Times notes, and while the seven-day average of new cases has risen to more than 72, from 25 last Saturday, the Israeli health ministry says only 26 of 729 active COVID-10 patients are hospitalized. Ran Balicer, an epidemiologist at Israeli health care organization Clalit, said he expects the high vaccination rate — especially among older Israelis — to keep the number of deaths and severe cases low.
The outbreak appears to have spread beyond Modiin and Binyamina, but "my guess is that we will not see a fourth wave," Israeli coronavirus czar Dr. Nachman Ash told Haaretz on Friday. The number of active cases is doubling every few days, he added, but "the rate is high because there are relatively few cases. As more cases are found, we don't expect it to continue at this [exponential] rate."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Road trip: New England’s maple syrup season
Feature New England is serving up maple syrup in delicious and unexpected ways
By The Week US Published
-
Music Reviews: Mdou Moctar, Panda Bear, and Tate McRae
Feature “Tears of Injustice,” “Sinister Grift,” and “So Close to What”
By The Week US Published
-
What's at stake in the Mahmoud Khalil deportation fight?
Talking Points Vague accusations and First Amendment concerns
By Joel Mathis, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published